ResearchAugust 13, 2026

New Trial Tests a JAK-Inhibitor Drug That Targets the Immune Signal Driving IBM Inflammation

A phase 2b clinical trial now recruiting in France is testing ruxolitinib — a JAK-inhibitor drug that blocks a key immune signal in IBM muscle — as a potential treatment for IBM.

Read more →
ResearchAugust 13, 2026

A Diabetes Drug Targeted IBM's Failing Muscle Energy in a New Clinical Trial

Researchers tested pioglitazone — a drug that boosts mitochondrial activity — in people with IBM. Muscle energy shifted in the lab, offering a window into whether fixing metabolism could help.

Read more →
ResearchAugust 13, 2026

A New Patient-Built Questionnaire Could Change How IBM Trials Measure Success

Researchers built the IBM-HI — a 97-item questionnaire developed with input from 569 people with IBM — to make sure future clinical trials measure the symptoms that actually matter to patients.

Read more →
ResearchAugust 13, 2026

Why IBM Muscles Struggle to Make Energy: New Mayo Clinic Study Finds Widespread Mitochondrial Damage

A new Mayo Clinic study published in the journal Brain finds that IBM muscle is impaired at nearly every step of energy production — which may help explain the profound fatigue so many patients feel.

Read more →
ResearchAugust 8, 2026

New Study Links Overactive IL-6 Inflammation in IBM Muscle to a Pathway Trials Are Already Targeting

A new peer-reviewed study found that the IL-6/JAK/STAT3 inflammation pathway is hyperactive in IBM muscle — and that the body's natural brakes on that pathway are weakened. Here is what it means.

Read more →
ResearchAugust 8, 2026

New Australian Collaboration Launches an IBM Pilot Trial — and a Way to Spot Progress Far Earlier

The Snow Centre for Immune Health, WEHI, and the Royal Melbourne Hospital are joining forces on a pilot clinical trial targeting immune pathways in IBM, with a focus on detecting treatment effects much earlier than current methods allow.

Read more →
ResearchJuly 23, 2026

How Common Is IBM? Large Study Reveals New Incidence Rates and Demographic Differences

A population-based study of over 4,000 IIM patients in England provides the most detailed picture yet of IBM incidence, showing it affects about 1 in 200,000 people per year and is more common in men.

Read more →
ResearchJuly 17, 2026

Gene Therapy Shows Promise in Mouse Model of Hereditary IBM

Researchers at Nationwide Children's Hospital used gene therapy to boost cellular cleanup pathways in a mouse model of hereditary IBM — and saw improvements in muscle function and protein buildup.

Read more →
ResearchJuly 17, 2026

Could Muscle Ultrasound Help Diagnose IBM? New Study Explores the Possibility

A study from Sapienza University in Rome found that muscle ultrasound — a quick, non-invasive, and affordable imaging tool — reflects the characteristic muscle damage pattern in IBM and correlates with MRI findings.

Read more →
ResearchJuly 17, 2026

Can At-Home Hand Exercises Help IBM Patients? A New Pilot Study Explores the Question

A small pilot study tested whether a simple at-home TheraPutty program could improve hand strength and function in IBM patients. Here is what the researchers found — and what it means.

Read more →
ResearchJuly 3, 2026

IBM Patients Face 2.5x Higher Fall Risk — And a New Tool Is Being Built to Track It

A study of 470 patients found IBM carries the highest fall risk of any inflammatory myopathy. Meanwhile, a new patient-reported outcome measure will help future clinical trials better capture what IBM actually feels like.

Read more →
ResearchJuly 2, 2026

New IBM Research Model Links Muscle Aging to Disease — And Points to New Treatment Targets

A breakthrough patient-derived cell model reveals that IBM muscle cells are inherently abnormal — with higher inflammation, DNA damage, and signs of premature aging. Plus, CAR T-cell therapy trials show promise for inflammatory myopathies.

Read more →
DiagnosisJune 21, 2026

"It's Just Aging" — Why That Diagnosis Might Be Wrong

If you've been told your muscle weakness is just part of getting older, you need to read this. IBM is the most commonly misdiagnosed muscle disease.

Read more →
Daily LivingJune 20, 2026

Exercise and IBM: Why Movement Matters More Than You Think

Exercise is the only current treatment recommendation for IBM. Here is what is safe, what to avoid, and how to start.

Read more →
TravelJune 19, 2026

Travelling with IBM: The Equipment You Need and How to Pack It

Travelling when you need a patient lift, portable commode, and other equipment seems impossible. Here is how to make it work.

Read more →
Daily LivingJune 18, 2026

Why Every IBM Patient Should Own a Bidet

When you can't wipe yourself, a bidet isn't a luxury — it's a medical necessity. Here is what to buy and why.

Read more →
FinancialJune 17, 2026

How to Apply for Disability Benefits with IBM

IBM qualifies for Social Security Disability Insurance. Here is how to apply, what documentation you need, and tips for a successful claim.

Read more →